Release of suit against AngioDynamics was not declared by a Delaware district court judge over patents for devices installed below the skin for effortlessness drug delivery. C.R. Bard Inc. stated that AngioDynamics had infringed on patents issued in 2013 and 2014 and AngioDynamics further added the claims as ineligible to be patented due to loss of description of specific items that can be patented [more].